Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of AC-1204 vs Caprylic Triglyceride Oil
NCT02747602Phase 1Completed
- Sponsor
- Cerecin
- Start
- Apr 2016
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tricaprilin in Alzheimer's disease (AD) (3 arms), sponsored by Cerecin. Primary endpoints: Area Under the Concentration-Time Curve for Total Ketones from Time 0 to Last Measurable Concentration, Area Under the Concentration-Time Curve for Total Ketones from Time 0 to Infinity and 5 more. Started Apr 2016; status: completed.
02
Drugs
tricaprilin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02747602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02747602.